Trial Profile
Tofacitinib: salvage therapy for patients with RCDII - a pilot study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2021
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Coeliac disease
- Focus Therapeutic Use
- Acronyms TOF-RCDII
- 25 Oct 2018 New trial record